28.03.2011 • News

3i Kicks Off Azelis Chemicals Sale

British private equity firm 3i Group has kicked off the sale of Azelis, a Belgium headquartered chemicals distributor with €1 billion euros in sales, people familiar with the situation said.

London-listed 3i has hired Bank of America Merrill Lynch to sell the company, which it acquired in 2007 in a €315 million deal, two people said.

The firm hopes to run a tightly controlled auction process, focusing on potential trade buyers, one of those people said. 3i declined to comment.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.